These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 16259317)

  • 21. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
    Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Kuca K; Musilek K
    Drug Chem Toxicol; 2010 Jul; 33(3):227-32. PubMed ID: 20429807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J; Jun D; Karasova J; Bajgar J; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
    Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
    Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
    J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro reactivation of acetylcholinesterase using the oxime K027.
    Kuca K; Kassa J
    Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
    Worek F; Koller M; Thiermann H; Wille T
    Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation potency of new group of acetylcholinesterase reactivators and their comparison with currently available oximes.
    Kuca K; Pícha J; Jun D
    Acta Medica (Hradec Kralove); 2006; 49(4):233-5. PubMed ID: 17438836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted monoquaternary oximes as reactivators of cyclosarin--and chlorpyrifos--inhibited acetylcholinesterase.
    Racakova V; Hrabinova M; Jun D; Kuca K
    Arh Hig Rada Toksikol; 2006 Dec; 57(4):387-90. PubMed ID: 17265677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods.
    Kassa J; Cabal J
    Pharmacol Toxicol; 1999 Jan; 84(1):41-5. PubMed ID: 9974189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
    Kuca K; Cabal J; Jun D; Musilek K
    Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro reactivating effects of standard and newly developed oximes on malaoxon-inhibited mouse brain acetylcholinesterase.
    dos Santos AA; dos Santos DB; Dafre AL; de Bem AF; Souza DO; da Rocha JB; Kuca K; Farina M
    Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):768-73. PubMed ID: 20406208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
    Maxwell DM; Koplovitz I; Worek F; Sweeney RE
    Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of potency of known oximes (pralidoxime, trimedoxime, HI-6, methoxime, obidoxime) to in vitro reactivate acetylcholinesterase inhibited by pesticides (chlorpyrifos and methylchlorpyrifos) and nerve agent (Russian VX).
    Musílek K; Kuca K; Jun D
    Acta Medica (Hradec Kralove); 2007; 50(3):203-6. PubMed ID: 18254274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.